PAVmed Announces Q3 2025 Financial Results and Updates

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.PAVmed ( (PAVM) ) has shared an announcement. On November 13, 2025, PAVmed Inc. announced a business update and financial results for the third quarter of 2025. The company highlighted significant advancements, including Veris Health’s commercial phase launch with The Ohio State University James Cancer Hospital and the relaunch of its implantable physiological monitor development. PAVmed also signed a letter of intent to license a new endoscopic imaging technology from Duke University, aiming to expand its innovation pipeline. Lucid Diagnostics reported $1.2 million in revenue from EsoGuard tests and received unanimous support for Medicare coverage, strengthening its financial position with a public stock offering. The company reported a GAAP net loss of $6.3 million for the quarter, with cash reserves increasing to $3.1 million. The most recent analyst rating on (PAVM) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on PAVmed stock, see the PAVM Stock Forecast page. Spark’s Take on PAVM Stock According to Spark, TipRanks’ AI Analyst, PAVM is a Neutral. PAVmed’s overall stock score is primarily impacted by its poor financial performance, characterized by severe profitability and liquidity challenges. Technical analysis provides a neutral outlook, while valuation suggests potential undervaluation but is overshadowed by financial instability. The absence of earnings call and corporate events data limits further insights. To see Spark’s full report on PAVM stock, click here. More about PAVmed PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. It focuses on innovative solutions, with subsidiaries like Lucid Diagnostics and Veris Health, enhancing its market presence. Average Trading Volume: 443,400 Technical Sentiment Signal: Sell Current Market Cap: $10.31M